C. Leport

C. Leport, X. Duval, C. Perronne, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Changing Profile of Infective Endocarditis

B. Hoen, C. Leport, N. Danchin, 2017 .

RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci

C. Leport, F. L’hériteau, P. Moreillon, 1995, Antimicrobial agents and chemotherapy.

Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review.

C. Leport, M. Delahousse, X. Duval, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS

F. Brun-Vézinet, C. Leport, D. Salmon, 1990, Journal of medical virology.

Effect of subinhibitory concentrations of antimicrobial agents on adherence to silicone and hydrophobicity of coagulase-negative staphylococci.

C. Leport, J. Pocidalo, J. Vildé, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients

F. Raffi, C. Leport, N. Duchange, 2005, European Journal of Human Genetics.

Determinants of Cerebral Lesions in Endocarditis on Systematic Cerebral Magnetic Resonance Imaging: A Prospective Study

N. Al-Attar, B. Iung, I. Klein, 2013, Stroke.

Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients.

P. Morlat, C. Leport, O. Benveniste, 2008, AIDS research and human retroviruses.

Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter.

F. Carrat, C. Leport, V. Enouf, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors

P. Ravaud, C. Leport, C. Jestin, 2007, AIDS.

A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?

C. Leport, A. Gervais, P. Longuet, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors Associated with Mortality in Human Immunodeficiency Virus Type 1–Infected Adults Initiating Protease Inhibitor–Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO–ANRS EP11 Study)

R. Salamon, L. Cuzin, F. Raffi, 2002 .

Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus.

F. Brun-Vézinet, C. Leport, C. Mandet, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study

M. Dupon, F. Raffi, C. Leport, 2009, Journal of acquired immune deficiency syndromes.

A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients

P. Morlat, F. Raffi, C. Michelet, 1997, AIDS.

Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.

Y. Lévy, F. Collin, C. Leport, 2008, The Journal of antimicrobial chemotherapy.

Ocular toxoplasmosis in human immunodeficiency virus-infected patients.

C. Katlama, C. Leport, P. Lehoang, 1992, American journal of ophthalmology.

Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA

R. Salamon, L. Cuzin, F. Raffi, 2002, The Journal of infectious diseases.

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.

C. Leport, C. Estellat, X. Duval, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fever of unknown origin in HIV‐infected patients: a critical analysis of a retrospective series of 57 cases

C. Leport, F. Bissuel, C. Perronne, 1994, Journal of internal medicine.

Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV?

C. Leport, C. Perronne, J. Vildé, 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Low alcohol consumption as a predictor of higher CD4+ cell count in HIV-treated patients: a french paradox or a proxy of healthy behaviors? The ANRS APROCO-COPILOTE CO-08 cohort.

F. Raffi, M. Carrieri, C. Protopopescu, 2014, Journal of acquired immune deficiency syndromes.

High levels of IL‐10 and determination of other cytokines and chemokines in HIV‐associated haemophagocytic syndrome

D. Dormont, C. Leport, O. Benveniste, 2000, Clinical and experimental immunology.

Antibiotic prophylaxis for infective endocarditis.

C. Leport, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal.

F. Raffi, C. Michelet, C. Leport, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Procedures associated with infective endocarditis in adults

B. Hoen, S. Briançon, C. Leport, 1995 .

Characterization of pandemic influenza immune memory signature after vaccination or infection.

A. Samri, B. Autran, F. Carrat, 2014, The Journal of clinical investigation.

Community acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT-scan indication.

Y. Yazdanpanah, C. Leport, Y. Claessens, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Efavirenz-Induced Decrease in Plasma Amprenavir Levels in Human Immunodeficiency Virus-Infected Patients and Correction by Ritonavir

C. Leport, R. Farinotti, G. Peytavin, 2000, Antimicrobial Agents and Chemotherapy.

The effect of Depressive Symptoms at ART Initiation on HIV Clinical Progression and Mortality: Implications in Clinical Practice

M. Carrieri, C. Leport, B. Spire, 2007, Antiviral therapy.

Experimental colonization of a polyester vascular graft with Staphylococcus aureus: a quantitative and morphologic study.

R. Guidoin, C. Leport, C. Lebrault, 1988, Journal of vascular surgery.

Multi-sectorial research is paramount for preventing and controlling emerging infectious diseases

J. Guégan, B. Hoen, C. Leport, 2019, Revue d'Épidémiologie et de Santé Publique.

High heterogeneity in community-acquired pneumonia inclusion criteria: does this impact on the validity of the results of randomized controlled trials?

C. Leport, C. Flateau, Y. Claessens, 2018, BMC Infectious Diseases.

Serum carcinoembryonic antigen: a prognostic marker in HIV-related Pneumocystis carinii pneumonia.

J. Lucet, M. Wolff, C. Leport, 1992, Scandinavian journal of infectious diseases.

Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.

C. Leport, N. Duchange, C. Hervé, 2002, Pharmacogenetics.

All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2012, International journal of epidemiology.

Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS.

C. Leport, D. Salmon, J. Vildé, 1991, The Journal of infectious diseases.

Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study

C. Lacroix, C. Leport, M. Torchet, 1991, Annals of neurology.

The spectrum of changes on 20 nerve biopsies in patients with HIV infection

J. Hauw, F. Brun-Vézinet, C. Leport, 1989, Muscle & nerve.

Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy.

C. Katlama, D. Costagliola, C. Leport, 2003, AIDS.

Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients

P. Morlat, F. Raffi, C. Leport, 2000, Antimicrobial Agents and Chemotherapy.

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

J. Moatti, C. Leport, B. Spire, 2001, AIDS.

Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group.

R. Salamon, B. Luft, P. Morlat, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Comparison of infective endocarditis in patients with and without previously recognized heart disease.

B. Hoen, S. Briançon, C. Leport, 1996, The American journal of cardiology.

Clinical and bacterial features of infections caused by Streptococcus milleri.

C. Leport, J. Molina, C. Michon, 1991, Scandinavian journal of infectious diseases.

Chronic Q Fever: Ninety-two Cases From France, Including 27 Cases Without Endocarditis

D. Raoult, M. Drancourt, P. Brouqui, 1993 .

Factors Associated With Nonadherence to Highly Active Antiretroviral Therapy: A 5-Year Follow-Up Analysis With Correction for the Bias Induced by Missing Data in the Treatment Maintenance Phase

J. Moatti, J. Cassuto, F. Raffi, 2006, Journal of acquired immune deficiency syndromes.

Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study

F. Alla, B. Iung, T. Doco‐Lecompte, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?

B. Iung, A. Péchinot, T. Doco‐Lecompte, 2022, Infectious Diseases and Therapy.

Staphylococcus aureus CC30 Lineage and Absence of sed,j,r-Harboring Plasmid Predict Embolism in Infective Endocarditis

F. Alla, F. Vandenesch, C. Leport, 2018, Front. Cell. Infect. Microbiol..

Association of Epstein-Barr virus with lethal midline granuloma.

G. de Thé, C. Leport, C. Perronne, 1985, The New England journal of medicine.

Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: a prospective survey.

C. Leport, J. Mainardi, F. Goldstein, 1998, The Journal of infection.

EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

W. Rozenbaum, B. Régnier, C. Leport, 1988, The Lancet.

Incidence, Medical and Socio-Behavioural Predictors of Psychiatric Events in An 11-Year Follow-Up of HIV-Infected Patients on Antiretroviral Therapy

M. Carrieri, C. Protopopescu, C. Leport, 2012, Antiviral therapy.

Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France.

B. Hoen, S. Briançon, C. Leport, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Failure of spiramycin to prevent neurotoxoplasmosis in immunosuppressed patients.

C. Katlama, B. Régnier, C. Leport, 1986, JAMA.

Short communication: Paraoxonase 1 (PON1) in French HIV-infected patients under antiretroviral therapy: relationship with the metabolic syndrome and inflammation.

C. Volteau, F. Raffi, C. Leport, 2013, AIDS research and human retroviruses.

Docetaxel in anthracycline‐pretreated AIDS‐related Kaposi's sarcoma: a retrospective study

C. Leport, B. Crickx, V. Descamps, 2005, The British journal of dermatology.

Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors

C. Leport, C. Chochillon, F. Damond, 1996, Antimicrobial agents and chemotherapy.

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: Efficacy of long-term continuous therapy

C. Katlama, B. Régnier, F. Raffi, 1988 .

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

P. Massip, C. Leport, P. Lutun, 1989, Antimicrobial Agents and Chemotherapy.

Need for integrative thinking to fight against emerging infectious diseases. Proceedings of the 5th seminar on emerging infectious diseases, March 22, 2016 – current trends and proposals

J. Guégan, C. Leport, J. Manuguerra, 2017, Revue d'Épidémiologie et de Santé Publique.

[Epidemiology of bacterial endocarditis in France in 1991].

R. Écochard, B. Hoen, S. Briançon, 1993, Archives des maladies du coeur et des vaisseaux.

Life Expectancy in Hospitalized Patients with AIDS: Prognostic Factors on Admission

J. le Gall, C. Leport, P. Flandre, 1996, Journal of palliative care.

Resting energy expenditure is increased in stable, malnourished HIV-infected patients.

C. Leport, J. Melchior, F. Vachon, 1991, The American journal of clinical nutrition.

[Lipodystrophy: a complication of protease inhibitors in HIV seropositive patients].

V. Ravery, L. Boccon-Gibod, C. Leport, 1999, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Hypoglycaemia and Diabetes Mellitus Following Parenteral Pentamidine Mesylate Treatment in AIDS Patients

C. Leport, C. Perronne, R. Assan, 1990, Diabetic medicine : a journal of the British Diabetic Association.

Fifty casesoflate prosthetic valveendocarditis: improvement inprognosis over a 15year period

C. Leport, C. Gaudebout, J. Vildé, 2017 .

Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.

C. Leport, X. Anglaret, C. Perronne, 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Long term evolution of adult onset Still ' s disease seen in an infectious diseases

C. Leport, B. Godeau, C. Perronne, 2022 .

Viremia Copy-Years as a Predictive Marker of All-Cause Mortality in HIV-1–Infected Patients Initiating a Protease Inhibitor–Containing Antiretroviral Treatment

B. Hoen, J. Cassuto, F. Raffi, 2015, Journal of acquired immune deficiency syndromes.

Tubulopathy Consecutive to Tenofovir-containing Antiretroviral Therapy in Two Patients Infected with Human Immunodeficiency Virus-1

C. Leport, G. Peytavin, X. Duval, 2004, Scandinavian journal of infectious diseases.

Response to combination antiretroviral therapy: variation by age

A. d’Arminio Monforte, C. Sabin, M. Battegay, 2008, AIDS.

Optimized Antiretroviral Therapy with Darunavir/Ritonavir, Etravirine and/or Raltegarvir: A Salvage Therapy Option in HIV-1 Infected Patients with Long-Term Therapeutic Failures, about 23 Cases

F. Raffi, C. Leport, E. Kendjo, 2012 .

Nevirapine use is associated with higher bone mineral density in HIV-I positive patients on long-term antiretroviral therapy.

J. Haymann, F. Raffi, C. Leport, 2019, AIDS research and human retroviruses.

Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors.

R. Salamon, B. Masquelier, J. Moatti, 2001 .

Clinical, Biologic, and Behavioral Predictors of Early Immunologic and Virologic Response in HIV‐Infected Patients Initiating Protease Inhibitors

R. Salamon, B. Masquelier, J. Moatti, 2001, Journal of acquired immune deficiency syndromes.

Is phosphatemia the best tool to monitor renal tenofovir toxicity?

C. Leport, G. Peytavin, A. Gervais, 2007, Journal of acquired immune deficiency syndromes.

An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.

C. Leport, S. Bastuji‐Garin, D. Salmon, 1989, The Journal of infectious diseases.

Immunoblot Proﬁle as Predictor of Toxoplasmic Encephalitis in Patients Infected with Human Immunodeﬁciency Virus

J. Miro, B. Luft, P. Morlat, 2001 .

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

C. Morrison, F. Brun-Vézinet, F. Dabis, 2017, The Journal of antimicrobial chemotherapy.

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.

H. Fleury, F. Raffi, C. Michelet, 2002, The Journal of infectious diseases.

Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients.

C. Leport, M. Kahn, C. Perronne, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed dacron graft

C. Leport, C. Lebrault, J. Pechère, 1991, Annals of vascular surgery.

Varicella in Patients Infected With the Human Immunodeficiency Virus

M. Lazanas, C. Leport, D. Salmon, 1990 .

Varicella in patients infected with the human immunodeficiency virus.

M. Lazanas, C. Leport, D. Salmon, 1990, Archives of dermatology.

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

M. Kazatchkine, D. Costagliola, S. Grabar, 2000, Annals of Internal Medicine.

Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group.

R. Salamon, B. Luft, P. Morlat, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of Toxoplasmic Encephalitis in Patients with AIDS

N Clumeck, J. McCutchan, B. Luft, 1992, Annals of Internal Medicine.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Anne M Johnson, Hansjakob Furrer, Peter Reiss, 2013, PLoS medicine.

Bacterial prostatitis in patients infected with the human immunodeficiency virus.

C. Leport, F. Rousseau, D. Salmon, 1989, The Journal of urology.

Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French National Survey.

P. Ambroise‐Thomas, J. Lucet, C. Leport, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Treatment of Cytomegalovirus infection].

C. Leport, D. Salmon, 1990, La Revue du praticien.

Failure of valacyclovir for herpes zoster in a moderately immunocompromised HIV-infected patient.

C. Leport, A. Gervais, X. Duval, 2004, AIDS patient care and STDs.

Cytomegalovirus colitis in HIV‐1-infected patients: a prospective research in 55 patients

C. Leport, J. Vildé, H. Mentec, 1994, AIDS.

Topical cidofovir for bowenoid papulosis in an HIV‐infected patient

C. Leport, B. Crickx, V. Descamps, 2001, The British journal of dermatology.

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study

C. Katlama, C. Chastang, F. Raffi, 1997, AIDS.

Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy.

C. Katlama, C. Leport, C. Sarfati, 1997, AIDS.

Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection.

Xavier Duval, Bruno Hoen, François Alla, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quantitation of cytomegalovirus (CMV) DNA by real‐time PCR for occurrence of CMV disease in HIV‐infected patients receiving highly active antiretroviral therapy

C. Katlama, D. Costagliola, C. Leport, 2003, Journal of medical virology.

Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients.

F. Brun-Vézinet, C. Leport, F. Bissuel, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients

C. Katlama, D. Costagliola, C. Leport, 2000, AIDS.

Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors.

D. Costagliola, C. Leport, F. Chapuis, 1998, AIDS.

Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

Keiji Fukuda, Mark A. Jacobson, Cynthia L. Sears, 2002 .

Necrotizing retinitis and cerebral vasculitis due to varicella-zoster virus in patients infected with the human immunodeficiency virus.

C. Leport, F. Rousseau, C. Perronne, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis E antibodies and HIV status

F. Brun-Vézinet, C. Leport, F. Bissuel, 1996, The Lancet.

Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.

R. Salamon, M. Dupon, P. Morlat, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

C. Katlama, D. Costagliola, C. Leport, 2000, AIDS.

Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.

F. Brun-Vézinet, C. Leport, I. Carrière, 1999, Clinical Infectious Diseases.

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

F. Brun-Vézinet, J. Moatti, J. Cassuto, 2002, AIDS.

Comparative Trial of Acyclovir and Vidarabine in Disseminated Varicella‐Zoster Virus Infections in Immunocompromised Patients

F. Brun-Vézinet, C. Leport, J. Vildé, 1986, Journal of medical virology.

Cotrimoxazole for prenatal treatment of congenital toxoplasmosis?

F. Derouin, C. Leport, É. Jacqz-Aigrain, 2000, Parasitology today.

Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus.

F. Brun-Vézinet, C. Leport, C. Perronne, 1993, The Journal of infectious diseases.

Occult hepatitis B in HIV-HCV coinfected patients

C. Leport, G. Chêne, A. Gervais, 2008, Scandinavian journal of infectious diseases.

Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination

C. Leport, G. Peytavin, D. Descamps, 2007, AIDS.

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

France Mentré, Xavier Duval, Christine Katlama, 2005, Clinical pharmacokinetics.

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.

C. Leport, F. Gueyffier, B. Lina, 2012, Antiviral research.

Effect of Oseltamivir, Zanamivir or Oseltamivir– Zanamivir Combination Treatments on Transmission of Influenza in Households

A. Flahault, F. Tubach, F. Carrat, 2012, Antiviral therapy.

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

F. Tubach, C. Leport, B. Lina, 2010, PLoS medicine.

Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir.

C. Leport, O. Benveniste, X. Duval, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Herpes simplex virus type 2 DNA in cerebrospinal fluid of a woman with recurrent meningitis.

C. Leport, F. Rozenberg, O. Lortholary, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

C. Katlama, J. Moatti, C. Leport, 2003, Journal of acquired immune deficiency syndromes.

J. Ragnaud, W. Rozenbaum, J. Capeau, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART

J. Moatti, F. Raffi, C. Leport, 2001, HIV clinical trials.

Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with Ritonavir

C. Leport, F. Clavel, G. Peytavin, 2002, Antimicrobial Agents and Chemotherapy.

Peroxisome proliferator activating receptor alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: the ANRS CO8 APROCO-COPILOTE study.

F. Raffi, C. Leport, G. Chêne, 2012, AIDS research and human retroviruses.

Low prevalence of active parvovirus B19 infection in HIV-infected patients

C. Leport, F. Morinet, M. Leruez-Ville, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Cardiac Tamponade due to Nocardiaasteroides

C. Leport, P. Mckeown, P. Wallach, 2017 .

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

J. Sterne, A. d’Arminio Monforte, M. Egger, 2003, The Lancet.

STAPHYLOCOCCUS LUGDUNENSIS ENDOCARDITIS

C. Leport, J. Etienne, C. Perronne, 1989, The Lancet.

Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV‐infected patients

R. Salamon, B. Luft, P. Morlat, 1996, AIDS.

Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey.

P. Ambroise‐Thomas, C. Katlama, C. Leport, 1994, Medicine.

[Toxoplasmosis in AIDS].

C. Leport, J. Remington, 1992, Presse medicale.

Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.

B. Luft, J. Fuhrer, C. Leport, 1993, The New England journal of medicine.

Treatment of acute toxoplasmosis with intravenous clindamycin

J. McCutchan, B. Luft, P. Morlat, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Antibiotic prophylaxis of late bacteremic vascular graft infection in a dog model.

C. Leport, C. Lebrault, J. Pechère, 1990, Annals of vascular surgery.

Mechanisms of ceftriaxone prophylaxis against late bacteremic vascular graft infection caused byStaphylococcus aureus in a dog model

C. Leport, C. Lebrault, J. Pechère, 1991, Annals of vascular surgery.

Experimental Bacteremic Vascular Graft Infection with Staphylococcus aureus. Comparative Colonization of Two Graft Materials and Prophylaxis of Late Infection

C. Leport, C. Lebrault, J. Pechère, 1990 .

Experimental colonization of an expanded polytetrafluoroethylene vascular graft with Staphylococcus aureus: a quantitative and morphologic study.

R. Guidoin, C. Leport, C. Lebrault, 1987, Journal of vascular surgery.

Ruptured mycotic pulmonary artery aneurysm: an unusual complication of right-sided endocarditis.

B. Régnier, M. Wolff, C. Leport, 1998, Scandinavian journal of infectious diseases.

Experimental colonization of a polyester vascular graft with : A quantitative and morphologic study

R. Guidoin, C. Leport, C. Lebrault, 1988 .

Experimental colonization of an expanded polytetrafluoroethylene vascular graft with : A quantitative and morphologic study

R. Guidoin, C. Leport, C. Lebrault, 1987 .

[Chronic bone infections after surgery. Treatment with the new quinolones].

C. Leport, B. Godeau, D. Salmon, 1989, Presse medicale.

INCIDENCE OF COLONIC LESIONS IN STREPTOCOCCUS BOVIS AND ENTEROCOCCAL ENDOCARDITIS

C. Leport, J. Vildé, A. Bure, 1987, The Lancet.

Progression to AIDS or Death as Endpoints in HIV Clinical Trials

H. Fleury, F. Raffi, C. Leport, 2001, HIV clinical trials.

Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome

C. Katlama, C. Rouzioux, B. Régnier, 1988, Digestive Diseases and Sciences.

Long‐term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs

P. Massip, F. Raffi, F. Collin, 2007, HIV medicine.

Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.

A. Macrez, J. Lucet, C. Leport, 2007, The Journal of hospital infection.

Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.

J. Moatti, F. Raffi, C. Leport, 2002, Social science & medicine.

Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.

A. Flahault, C. Leport, J. Estaquier, 2005, The Journal of infectious diseases.

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.

C. Leport, S. Pavy, X. Duval, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term Combination Antiretroviral Therapy Reach Same Mortality Rates as the General Population

C. Katlama, M. Dupon, P. Morlat, 2007, Journal of acquired immune deficiency syndromes.

F. Raffi, C. Leport, B. Spire, 2004, AIDS care.

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

R. Salamon, F. Brun-Vézinet, C. Katlama, 2017, The Journal of antimicrobial chemotherapy.

Possible Mechanism of Toxicity of Zidovudine by Induction of Apoptosis of CD4+ and CD8+ T-Cells in Vivo

C. Leport, J. Estaquier, J. Lelièvre, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

F. Raffi, M. Carrieri, C. Protopopescu, 2007, Quality of Life Research.

[Myocardial localisation of tuberculosis: the diagnostic value of cardiac MRI].

C. Leport, J. Laissy, J. Vildé, 2005, Presse medicale.

Pregnancy may be followed by an inflexion of the immune reconstitution in HIV‐infected women who receive antiretroviral drugs before conception

C. Leport, C. Lewden, G. Chêne, 2008, HIV medicine.

C. Michelet, C. Leport, B. Spire, 2005, Journal of psychosomatic research.

Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study

M. Dupon, L. Cuzin, F. Raffi, 2016, PloS one.

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.

D. Arveiler, J. Ruidavets, P. Amouyel, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low to medium-low risk perception for dengue, chikungunya and Zika outbreaks by infectious diseases physicians in France, Western Europe

J. Guégan, C. Leport, S. Alfandari, 2019, BMC Public Health.

Is long‐term virological response related to CCR5 Δ32 deletion in HIV‐1‐infected patients started on highly active antiretroviral therapy?

C. Katlama, F. Raffi, C. Leport, 2010, HIV medicine.

The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.

F. Raffi, C. Leport, B. Spire, 2003, AIDS.

Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants

V. Calvez, C. Delaugerre, C. Katlama, 2019, The Journal of antimicrobial chemotherapy.

Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.

R. Salamon, B. Luft, P. Morlat, 1996, The Journal of infectious diseases.

Acquired immunodeficiency syndrome (AIDS) in Africans.

F. Brun-Vézinet, C. Katlama, C. Rouzioux, 1984, Annales de la Societe belge de medecine tropicale.

Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy.

C. Charpentier, B. Masquelier, F. Raffi, 2011, The Journal of antimicrobial chemotherapy.

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV‐infected patients

F. Brun-Vézinet, C. Leport, G. Peytavin, 2004, HIV medicine.

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.

C. Katlama, J. Capeau, F. Raffi, 2019, Diabetes & metabolism.

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

C. Leport, O. Pajot, F. Mentré, 2004, AIDS.

Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.

C. Leport, P. Carrieri, P. Verger, 2014, Vaccine.

Venous access port--related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool.

C. Leport, J. Molina, P. Longuet, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.

Anne M Johnson, A. Mocroft, O. Kirk, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.

F. Raffi, M. Carrieri, C. Protopopescu, 2009, The Journal of antimicrobial chemotherapy.

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.

J. Capeau, F. Raffi, C. Leport, 2015, The Journal of antimicrobial chemotherapy.

Long-term evolution and determinants of renal function in HIV-infected patients who began receiving combination antiretroviral therapy in 1997-1999, ANRS CO8 APROCO-COPILOTE.

F. Raffi, C. Leport, J. Rossert, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-Term Evolution and Determinants of Renal Function in HIV-Infected Patients Who Began Receiving Combination Antiretroviral Therapy in 1997 – 1999 , ANRS CO 8 APROCO-COPILOTE

F. Raffi, C. Leport, J. Rossert, 2009 .

Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE Cohort

F. Raffi, C. Protopopescu, C. Leport, 2016, AIDS and Behavior.

Primary cytomegalovirus infection associated with the onset of ulcerative colitis

C. Leport, O. Lortholary, C. Perronne, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients.

B. Masquelier, M. Dupon, F. Raffi, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long term evolution of adult onset Still's disease seen in an infectious diseases department.

C. Leport, B. Godeau, M. Kahn, 1991, Annals of the rheumatic diseases.

Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia.

Xavier Duval, Charles Mayaud, F. Tubach, 2015, American journal of respiratory and critical care medicine.

Recommendations for the management of patients after heart valve surgery.

B. Prendergast, R. de Caterina, R. Hall, 2005, European heart journal.

Prophylaxis of infective endocarditis: current tendencies, continuing controversies.

Xavier Duval, C. Leport, X. Duval, 2008, The Lancet. Infectious diseases.

Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis.

Xavier Duval, F. Alla, S. Larrieu, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changing profile of infective endocarditis: results of a 1-year survey in France.

F. Alla, F. Vandenesch, B. Hoen, 2002, JAMA.

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality.

Xavier Duval, Bruno Hoen, François Alla, 2006, European heart journal.

Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy

L. Cuzin, F. Raffi, M. Carrieri, 2012, BMJ Open.

For peer review only CD4+ cell count ≥200 cells/mm3 and Moderate Alcohol Consumption: Evidence of Protection against Coronary and other Arterial Disease Events in an 11$year Cohort of HIV$ infected Patients on Antiretroviral Therapy

C. Leport, V. Reboud, S. Roux, 2012 .

Prolonged and fatal disseminated cytomegalovirus infection in an immunocompetent woman

C. Leport, F. Rousseau, P. Dény, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Unexplained fever and chronic fatigue: abnormal circadian temperature pattern.

C. Leport, J. Vildé, M. Janowski, 1992, The European journal of medicine.

Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe

O. Kirk, M. Egger, F. Dabis, 2017 .

Twelve-Year Mortality in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Social Vulnerability. The ANRS CO8 APROCO-COPILOTE cohort

M. Carrieri, C. Protopopescu, C. Michelet, 2015, Antiviral therapy.

Decreases in plasma TNF‐α level and IFN‐γ mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL‐2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV‐infected patients

D. Dormont, C. Leport, O. Benveniste, 2003, Clinical and experimental immunology.

Manifestations digestives du syndrome d'immunodéficience acquise (SIDA): étude chez 26 patients

B. Régnier, C. Leport, S. Matheron, 1985 .

1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus

David R. Holtgrave, R. Chaisson, N. Ampel, 1999, Annals of Internal Medicine.

Immunoblot Profile as Predictor of Toxoplasmic Encephalitis in Patients Infected with Human Immunodeficiency Virus

J. Miro, B. Luft, P. Morlat, 2001, Clinical Diagnostic Laboratory Immunology.

Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS

P. Morlat, F. Raffi, C. Leport, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis

C. Leport, J. Vildé, T. Niyongabo, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus

C. Leport, C. Perronne, J. Vildé, 1995, Antimicrobial agents and chemotherapy.

Levels of pyrimethamine in serum and penetration into brain tissue in humans.

C. Leport, A. Meulemans, G. Dameron, 1992, AIDS.

Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS

P. Morlat, C. Leport, J. Vildé, 1991, Antimicrobial Agents and Chemotherapy.

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.

C. Katlama, B. Régnier, F. Raffi, 1988, The American journal of medicine.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

J. Whitehead, F. Hayden, A. Hajeer, 2015, SpringerPlus.

Procedures associated with infective endocarditis in adults. A case control study.

B. Hoen, S. Briançon, C. Leport, 1995, European heart journal.

Bivariate linear mixed models using SAS proc MIXED

Daniel Commenges, Hélène Jacqmin-Gadda, Rodolphe Thiébaut, 2002, Comput. Methods Programs Biomed..

Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis

F. Alla, F. Vandenesch, C. Acar, 2017, Journal of the American Heart Association.

Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial

S. Chevret, C. Protopopescu, C. Leport, 2017, BMJ Open.

Factors Associated With Increased Serum Alanine Aminotransferase Levels During the French Guiana Dengue Epidemic of 2005-2006

A. Flahault, C. Leport, F. Djossou, 2010 .

All-cause mortality in treated HIV-infected adults with CD4 5500/mm compared with the general population: evidence from a large European observational cohort collaborationy

A. Mocroft, O. Kirk, M. Egger, 2022 .

Bivariate Longitudinal Model For The Analysis Of The Evolution Of Hiv Rna And Cd4 Cell Count In Hiv Infection Taking Into Account Left Censoring Of Hiv Rna Measures

H. Jacqmin-Gadda, C. Katlama, P. Morlat, 2003, Journal of biopharmaceutical statistics.

Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

M. Zwahlen, A. Mocroft, O. Kirk, 2020, Clinical Infectious Diseases.

[Prevention of toxoplasmosis in immunocompromised patients].

P. Morlat, C. Leport, 1997, Annales de medecine interne.

[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February].

P. Ambroise‐Thomas, C. Katlama, F. Derouin, 1996, Presse medicale.

Response to Highly Active Antiretroviral Therapy at 6 Months and Long-Term Disease Progression in HIV-1 Infection

M. Egger, M. Kazatchkine, D. Costagliola, 2005, Journal of acquired immune deficiency syndromes.

Living with HIV, Antiretroviral Treatment Experience and Tobacco Smoking: Results from a Multisite Cross-Sectional Study

G. Baron, P. Ravaud, F. Lert, 2008, Antiviral therapy.

Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study.

F. Brun-Vézinet, B. Masquelier, F. Raffi, 2002, The Journal of infectious diseases.

Preoperative use and safety of coronary angiography for acute aortic valve infective endocarditis

B. Iung, C. Leport, A. Vahanian, 2010, Heart.

endocarditis angiography for acute aortic valve infective Preoperative use and safety of coronary

B. Iung, C. Leport, A. Vahanian, 2022 .

Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.

C. Volteau, F. Raffi, C. Leport, 2012, AIDS research and human retroviruses.

Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease).

C. Leport, X. Duval, V. Le Moing, 2001, The American journal of medicine.

Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.

F. Derouin, C. Leport, R. Farinotti, 1998, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

Drug-to-drug interaction between dapsone and minocycline: An unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient

C. Leport, A. Gervais, S. Gallien, 2009, Scandinavian journal of infectious diseases.

[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].

C. Leport, J. Vildé, T. Niyongabo, 1991, Presse medicale.

Partial Rupture of the Tricuspid Valve after Extraction of Permanent Pacemaker Leads: Detection by Transesophageal Echocardiography

C. Leport, H. Benamer, E. Brochet, 1999, Pacing and clinical electrophysiology : PACE.

[Peripheral neuropathy in relation to LAV/HTLV III retrovirus infection. A clinical, anatomical and immunological study. 5 cases].

J. Hauw, F. Brun-Vézinet, C. Leport, 1987, Presse medicale.

Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy: standardization to the general population.

F. Raffi, C. Leport, C. Lewden, 2001, Journal of acquired immune deficiency syndromes.

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability

J. Ragnaud, F. Raffi, C. Protopopescu, 2012, AIDS care.

Characteristics and response to antiretroviral therapy of HIV‐1‐infected patients born in Africa and living in France

R. Salamon, F. Brun-Vézinet, C. Leport, 2007, HIV medicine.

Hemophagocytic Syndrome in the Course of Crohn's Disease: Possible Association With Cytomegalovirus Infection

C. Leport, O. Blétry, D. Bonnet, 2009, The American Journal of Gastroenterology.

Prevalence and Predictors of Deterioration of a Trustful Patient-Provider Relationship Among HIV-Infected Persons Treated With Antiretroviral Therapy

J. Ragnaud, F. Raffi, M. Carrieri, 2008, Journal of acquired immune deficiency syndromes.

Use of Neuraminidase Inhibitors in Primary Health Care during Pandemic and Seasonal Influenza between 2009 and 2013

C. Turbelin, C. Leport, T. Hanslik, 2015, Antiviral therapy.

Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy.

C. Leport, D. Horstkotte, D. Burckhardt, 1995, European heart journal.

[Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae].

C. Leport, C. Perronne, J. Vildé, 1993, Presse medicale.

Viruses detected by systematic multiplex polymerase chain reaction in adults with suspected community-acquired pneumonia attending emergency departments in France

C. Leport, Y. Claessens, L. Epelboin, 2015, Clinical Microbiology and Infection.

Update on opportunistic infections.

P. Reiss, C. Leport, J. Feinberg, 1997, Project Inform perspective.

[Acute cytomegalovirus infection revealing systemic lupus erythematosus].

C. Leport, M. Chauveheid, P. Longuet, 2011, La Revue de medecine interne.

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

J. Sterne, A. Sabin, A. Mocroft, 2018, HIV medicine.

[Treatment of severe staphylococcal infections. Failure of rifampicin in combination therapy. 4 cases].

B. Régnier, K. Lassoued, C. Leport, 1985, Presse medicale.

[Pneumopathies caused by Streptococcus pneumoniae in 27 HIV infected patients].

C. Leport, X. Duval, C. Perronne, 1995, Presse medicale.

Presence of numerous stop codons in HIV-1 reverse transcriptase proviral DNA sequences from patients with virological response to HAART

F. Brun-Vézinet, B. Masquelier, F. Raffi, 2006, AIDS.

[Infections and lupus].

C. Leport, V. Le Moing, 1998, La Revue du praticien.

Prognosis of HIV-1 infected drug naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration

J. Sterne, M. Egger, R. Hogg, 2002 .

Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections--the Fluco French cohort.

J. Desenclos, F. Carrat, C. Leport, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.

B. Luft, P. Morlat, C. Leport, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

David R. Holtgrave, M. Alter, J. Phair, 2002, Annals of internal medicine.

Modalities of palliative care in hospitalized patients with advanced AIDS

C. Leport, J. Vildé, P. Moulin, 2000, AIDS care.

Prophylaxis of infective endocarditis: French recommendations 2002

N Danchin, C. Leport, N. Danchin, 2005, Heart.

Prolonged medically recorded treatment interruptions among HIV-infected patients on highly active antiretroviral therapy with controlled viremia: when physicians have to juggle patient negotiation and guidelines.

C. Katlama, F. Raffi, M. Carrieri, 2010, Journal of acquired immune deficiency syndromes.

An Example of Nonrandom Missing Data for Hepatitis C Virus Status in a Prognostic Study Among HIV-Infected Patients

H. Jacqmin-Gadda, L. Cuzin, C. Leport, 2004, HIV clinical trials.

Infections à virus herpes simplex et à virus varicelle-zona chez les patients infectés par le VIH

C. Leport, F. Brun-vezinet, 1997 .

Characterization of pandemic influenza immune memory signature after vaccination or infection.

A. Samri, B. Autran, F. Carrat, 2014, The Journal of clinical investigation.

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.

C. Leport, F. Gueyffier, B. Lina, 2012, Antiviral research.

Cerebral Microbleeds Are Frequent in Infective Endocarditis: A Case–Control Study

B. Iung, I. Klein, C. Leport, 2009, Stroke.

Infective Endocarditis with Symptomatic Cerebral Complications: Contribution of Cerebral Magnetic Resonance Imaging

B. Iung, C. Leport, D. Messika‐Zeitoun, 2013, Cerebrovascular Diseases.

All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2012, International journal of epidemiology.

Evolution of Protease and Reverse Transcriptase Inhibitor Resistance-Associated Mutations in HIV-1-Infected Protease Inhibitor-Treated Patients with Persistent Low Viraemia

C. Leport, G. Peytavin, D. Descamps, 2005, Antiviral therapy.

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

David R. Holtgrave, M. Alter, J. Phair, 2002, Annals of internal medicine.

Running title : prevalence of anal cancer precursors Anal Squamous Intraepithelial Lesions and Condyloma in HIV-Infected Heterosexual Men , Homosexual Men and Women : Prevalence and Associated factors

P. Ravaud, C. Leport, C. Jestin, 2017 .

Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.

R. Salamon, B. Luft, C. Leport, 1998, Controlled clinical trials.

Expanding the spectrum of HIV-associated myopathy

C. Duyckaerts, T. Maisonobe, O. Dubourg, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis

B. Iung, I. Klein, C. Leport, 2010, Annals of Internal Medicine.

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

F. Tubach, C. Leport, B. Lina, 2010, PLoS Medicine.

2010 French SPILF-AFSSAPS guiding criteria for Streptococcus pneumoniae acute community-acquired pneumonia: evaluation in patients of the PACSCAN-ESCAPED cohort.

C. Leport, Y. Claessens, E. Varon, 2020, Medecine et maladies infectieuses.